Literature DB >> 8348955

Agonist pharmacology of the neuronal alpha 7 nicotinic receptor expressed in Xenopus oocytes.

M Amar1, P Thomas, C Johnson, G G Lunt, S Wonnacott.   

Abstract

The potencies and efficacies of seven agonists at chick alpha 7 nicotinic receptors expressed in Xenopus oocytes were determined by whole cell recording. (+)-Anatoxin-a was the most potent agonist (EC50 = 0.58 microM) and acetylcholine was the least potent (EC50 = 320 microM). The rank order of agonist potencies was: (+)-anatoxin-a >> cytisine > (-)-nicotine > (+)-nicotine > DMPP > 1-acetyl-4-methylpiperazine methiodide > acetylcholine. DMPP evoked only very small currents: comparison of maximally effective agonist concentrations showed that DMPP was only one-fifth as efficacious as other agonists. Previously published IC50 values for rat brain [125I]alpha-bungarotoxin sites show a similar agonist profile, and the identity of homo-oligomeric alpha 7 receptors with native alpha-bungarotoxin-sensitive neuronal nicotinic receptors is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8348955     DOI: 10.1016/0014-5793(93)81005-k

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  In vivo effects of the anatoxin-a on striatal dopamine release.

Authors:  F Campos; R Durán; L Vidal; L R F Faro; M Alfonso
Journal:  Neurochem Res       Date:  2006-05-09       Impact factor: 3.996

2.  Nicotinic stimulation produces multiple forms of increased glutamatergic synaptic transmission.

Authors:  K A Radcliffe; J A Dani
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

3.  Two distinct nicotinic receptors, one pharmacologically similar to the vertebrate alpha7-containing receptor, mediate Cl currents in aplysia neurons.

Authors:  J Kehoe; J M McIntosh
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

4.  Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine.

Authors:  C P Fenster; M F Rains; B Noerager; M W Quick; R A Lester
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

Review 5.  Alpha-7 nicotinic agonists for cognitive deficits in neuropsychiatric disorders: A translational meta-analysis of rodent and human studies.

Authors:  Alan S Lewis; Gerrit I van Schalkwyk; Michael H Bloch
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-01-05       Impact factor: 5.067

6.  Pharmacological and immunological identification of native alpha7 nicotinic receptors: evidence for homomeric and heteromeric alpha7 receptors.

Authors:  Raed A El-Hajj; Susan B McKay; Dennis B McKay
Journal:  Life Sci       Date:  2007-09-19       Impact factor: 5.037

7.  Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis.

Authors:  Roger L Papke; Julia K Porter Papke
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

Review 8.  Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning.

Authors:  Thomas J Gould; Prescott T Leach
Journal:  Neurobiol Learn Mem       Date:  2013-08-22       Impact factor: 2.877

Review 9.  Review of Cyanotoxicity Studies Based on Cell Cultures.

Authors:  Iliyana Sazdova; Milena Keremidarska-Markova; Mariela Chichova; Blagoy Uzunov; Georgi Nikolaev; Mitko Mladenov; Rudolf Schubert; Maya Stoyneva-Gärtner; Hristo S Gagov
Journal:  J Toxicol       Date:  2022-04-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.